Interest of Performing Two 6-minute Walk Tests at the End of a Pulmonary Rehabilitation Program, in COPD Patients.

In pulmonary rehabilitation, the 6-Minute Walk Test (6MWT) is essential to assess the effects of the program on patients' health. Current guidelines don't recommend to perform two 6MWT at the end of pulmonary rehabilitation. However, a more recent study shows that two 6MWT should be performed at the end of the program to accurately and reliably assess patients' capacities.

The aim of this study is to compare the results of two tests performed at the end of the program by COPD patients to find out whether there is a benefit of performing two 6MWT at the end of pulmonary rehabilitation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COPD Chronic Disease Disease Attributes Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Chu Brest

Brest, 29609, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient with stage 2 to 4 (A to D) COPD
Admitted to pulmonary rehabilitation unit of CH des Pays de Morlaix (CHPM)
To follow a pulmonary rehabilitation program (4 weeks)
Patient aged 18 or over
Patient able to formulate his non-opposition to participate in the study

Exclusion criteria

Contraindication to perform the 6-Minute Walk Test
Patient under legal protection
Refusal of participation

Treatment and study plan

Primary outcomes

6 minute walk distance (6MWD)

Time frame: Two hours

Comparison of the 6MWD between the first and the second 6-Minute walk test (6MWT) performed at the end of pulmonary rehabilitation program.

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Acronym: 2-TM6

Important dates

Study start: 2023
Primary completion: 2024
Study completion: 2024
First posted: May 9, 2023
Registry last updated: Sep 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed